Lotus Bio Technology Development Stock Cash Flow From Operations
| LBTD Stock | USD 0.01 0.00 0.00% |
Fundamental analysis of Lotus Bio allows traders to better anticipate movements in Lotus Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.
Lotus |
Lotus Bio Technology Development Company Cash Flow From Operations Analysis
Lotus Bio's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Lotus Bio Cash Flow From Operations | (17.75 K) |
Most of Lotus Bio's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lotus Bio Technology Development is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Lotus Bio Technology Development has (17,755) in Cash Flow From Operations. This is 100.0% lower than that of the Media (discontinued effective close of September 28, 2018) sector and 100.01% lower than that of the Consumer Discretionary industry. The cash flow from operations for all United States stocks is 100.0% higher than that of the company.
Lotus Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lotus Bio's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Lotus Bio could also be used in its relative valuation, which is a method of valuing Lotus Bio by comparing valuation metrics of similar companies.Lotus Bio is currently under evaluation in cash flow from operations category among its peers.
Lotus Fundamentals
| Return On Asset | -4.21 | |||
| Current Valuation | 31.31 M | |||
| Shares Outstanding | 782.77 M | |||
| Shares Owned By Insiders | 60.40 % | |||
| Price To Earning | (1.71) X | |||
| Net Income | (19.55 K) | |||
| Cash And Equivalents | 1 | |||
| Total Debt | 16.68 K | |||
| Cash Flow From Operations | (17.75 K) | |||
| Beta | -1.44 | |||
| Market Capitalization | 13.78 M | |||
| Total Asset | 5.46 K | |||
| Retained Earnings | (931 K) | |||
| Working Capital | (68 K) | |||
| Current Liabilities | 68 K | |||
| Net Asset | 5.46 K |
About Lotus Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lotus Bio Technology Development's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Bio Technology Development based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Lotus Pink Sheet
Lotus Bio financial ratios help investors to determine whether Lotus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Bio security.